Skip to main content
Contact Us
Subscribe
E-Edition
73°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about DSNKY
Recent news which mentions DSNKY
DSNKY Stock Earnings: Daiichi Sankyo Co Reported Results for Q1 2024
August 13, 2024
Tickers
DSNKY
Tags
OTC:DSNKY
DSNKY
Market News
From
InvestorPlace
Recession-Resilient Asian Stock Picks: TSMC, SK Hynix Among This Analyst's Top 10
August 07, 2024
Tickers
ALCPF
ASIA
DSKYF
DSNKY
Tags
HXSCL
Expert Ideas
Long Ideas
From
Benzinga
Merck's Q2 Earnings: Revenue And EPS Beat Helped By Strong Keytruda Sales, But Acquisition Costs Bites Into Annual Profit Forecast
July 30, 2024
Tickers
DSKYF
DSNKY
MRK
NEWS
Tags
DSNKY
General
Briefs
From
Benzinga
The 3 Most Undervalued Nasdaq 100 Stocks to Buy in July 2024
July 15, 2024
Tickers
AZN
CHTR
COST
DSNKY
Tags
AZN
DSNKY
NASDAQ:CHTR,NASDAQ:GILD,NASDAQ:COST,NASDAQ:TSLA,NASDAQ:AZN,OTCMKTS:DSNKY
From
InvestorPlace
FDA Declines To Approve Merck-Daiichi Sankyo Partnered Lung Cancer Drug
June 27, 2024
Tickers
DSKYF
DSNKY
MRK
NEWS
Tags
FDA
General
DSNKY
From
Benzinga
Why Is AstraZeneca Stock Trading Lower On Tuesday?
May 28, 2024
Tickers
AZN
DSKYF
DSNKY
NEWS
Tags
Briefs
Movers
Biotech
From
Benzinga
DSNKY Stock Earnings: Daiichi Sankyo Co Reported Results for Q3 2023
April 30, 2024
Tickers
DSNKY
Tags
Market News
Earnings Reports
OTCMKTS:DSNKY
From
InvestorPlace
Double Good News For AstraZeneca's Breast Cancer Drugs
April 29, 2024
Tickers
AZN
DSKYF
DSNKY
NEWS
Tags
General
DSNKY
Briefs
From
Benzinga
AstraZeneca/Daiichi's Flagship Drug Enhertu Secures Accelerated FDA Approval For Pretreated Cancer Patients With Solid Tumor
April 08, 2024
Tickers
AZN
DSKYF
DSNKY
NEWS
Tags
AZN
DSNKY
FDA
From
Benzinga
What's Going On With Pfizer Stock Today?
January 25, 2024
Tickers
DSKYF
DSNKY
NEWS
PFE
Tags
PFE
Briefs
Biotech
From
Benzinga
Why Pharmaceutical Company Esperion Therapeutics Shares Are Diving Today
January 03, 2024
Tickers
DSNKY
ESPR
NEWS
Tags
why it's moving
Market News
Markets
From
Benzinga
Japan Emerges As Promising 2024 Investment Destination: 3 Stocks To Consider
December 20, 2023
Tickers
ASIA
CCOEY
DSNKY
EWJ
Tags
Japan
Belinda Bao
Market News
From
Benzinga
Merck Just Made a Big Move -- but Will It Be Enough for Investors Right Now?
October 31, 2023
Tickers
DSNKY
MRK
Tags
MRK
DSNKY
Recent Press Releases
From
Motley Fool
Better Than Chemotherapy - AstraZeneca/Daiichi Sankyo Partnered Cancer Drug Meets Primary Goal In Breast Cancer Setting
September 22, 2023
Tickers
AZN
DSKYF
DSNKY
Tags
Large Cap
DSKYF
Briefs
From
Benzinga
AstraZeneca's Reinforces Hold In Lung Cancer Settings: Touts Promising Data From Three Trials
September 11, 2023
Tickers
AZN
DSKYF
DSNKY
Tags
DSNKY
General
Briefs
From
Benzinga
FDA Greenlights Daiichi Sankyo's Blood Cancer Drug, A Promising Competitor to Novartis' Rydapt
July 21, 2023
Tickers
DSKYF
DSNKY
NVS
Tags
NVS
Market News
ALMPY
From
Benzinga
Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More
July 04, 2023
Tickers
BETRF
CYBN
DMTTF
DSNKY
Tags
Events
Guidance
DMTTF
From
Benzinga
AstraZeneca Shares Under Pressure On Some Adverse Events In Late-Stage Lung Cancer Drug Trial
July 03, 2023
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
Briefs
premarket trading
Benzinga
From
Benzinga
Japanese Pharma Company Sponsors Australian Start Up In Development Of Non-Hallucinogenic Medicines
June 27, 2023
Tickers
DSNKY
Tags
DSNKY
Psychedelic/Assisted Therapies
Management
From
Benzinga
Daiichi, Zymeworks Terminate Seven Year-Cancer Antibody Pact
March 20, 2023
Tickers
DSKYF
DSNKY
ZYME
Tags
Contracts
ZYME
Market News
From
Benzinga
First Republic Bank sinks on possible sale reports, and Credit Suisse’s stock boosted by central bank borrowing
March 16, 2023
Tickers
ADBE
BIDU
CS
DSNKY
Tags
ESPR
SNAP
PTRA
From
MarketWatch
AstraZeneca-Daiichi Sankyo's Flagship Cancer Drug Shows Meaningful, Durable Responses In Other Solid Tumor Setting
March 06, 2023
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
General
DSNKY
AZNCF
From
Benzinga
Is Gilead Sciences a Good Stock to Buy Now?
February 06, 2023
Tickers
AZN
DSNKY
GILD
PFE
Tags
Recent Press Releases
Market News
GILD
From
Motley Fool
Daiichi Sankyo Seeks Approval In Japan For Its mRNA-Based COVID-19 Vaccine
January 13, 2023
Tickers
DSKYF
DSNKY
Tags
General
DSNKY
COVID/19 Vaccine
From
Benzinga
AstraZeneca - Daiichi Sankyo's Enhertu Wins European Approval For Gastric Cancer, CHMP Backs Other Cancer Drugs
December 19, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
DSNKY
General
AZNCF
From
Benzinga
AstraZeneca Highlights First Results From Datopotamab Study In Pretreated Breast Cancer Patients
December 09, 2022
Tickers
AZN
AZNCF
DSNKY
Tags
DSNKY
General
AZNCF
From
Benzinga
European Medicines Agency's Advisory Committee Backs Approval Of AstraZeneca's Three Cancer Drugs
November 14, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
Briefs
Benzinga
Biotech
From
Benzinga
With Upcoming Contentious Meeting, This Analyst Cuts Price Target On Spectrum Pharma
September 21, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
General
DSNKY
AZNCF
From
Benzinga
Why MacroGenics Stock Sank Today
September 12, 2022
Tickers
DSNKY
MGNX
Tags
MGNX
DSNKY
Recent Press Releases
From
Motley Fool
This Cancer Focused Stock Has 60% Potential Upside, Bullish Analyst Says
September 12, 2022
Tickers
DSNKY
RAIN
Tags
Price Target
Briefs
Benzinga
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.